Work for Aurinia Pharmaceuticals Inc.?
Claim Your Profile
Upgrade your company profile to unlock all of your annual report content on AnnualReports.com
Aurinia Pharmaceuticals Inc. has reached its limit for free report views.
Upgrade your company profile to unlock all of your annual report content on AnnualReports.com
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company is headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.
